Growth Metrics

Zimmer Biomet Holdings (ZBH) Change in Accured Expenses (2016 - 2026)

Zimmer Biomet Holdings has reported Change in Accured Expenses over the past 18 years, most recently at -$183.0 million for Q1 2026.

  • For Q1 2026, Change in Accured Expenses fell 402.75% year-over-year to -$183.0 million; the TTM value through Mar 2026 reached -$44.8 million, up 81.26%, while the annual FY2025 figure was $101.8 million, 131.61% up from the prior year.
  • Change in Accured Expenses for Q1 2026 was -$183.0 million at Zimmer Biomet Holdings, down from $112.9 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $164.2 million in Q4 2023 and troughed at -$183.0 million in Q1 2026.
  • A 5-year average of -$20.9 million and a median of -$34.3 million in 2023 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: crashed 477.36% in 2023 and later soared 223.67% in 2025.
  • Year by year, Change in Accured Expenses stood at $104.6 million in 2022, then surged by 56.98% to $164.2 million in 2023, then tumbled by 171.44% to -$117.3 million in 2024, then soared by 196.25% to $112.9 million in 2025, then tumbled by 262.09% to -$183.0 million in 2026.
  • Business Quant data shows Change in Accured Expenses for ZBH at -$183.0 million in Q1 2026, $112.9 million in Q4 2025, and -$51.5 million in Q3 2025.